New students: get 15% off your first order with code WELCOME15 Claim offer

TUTORSGALLERY STUDY.
Track Order Get a Quote
admin 1 min read Nursing

[Verified Answer]: In patients with T2D and chronic kidney…

In patients with T2D and chronic kidney disease (CKD), why might a sodium-glucose co-transporter 2 (SGLT2) inhibitor be preferred over a GLP-1 RA? A. SGLT2 inhibitors reduce weight more effectively B. SGLT2 inhibitors have more primary evidence demonstrating benefit in CKD C. GLP-1 RAs are contraindicated in CKD D. SGLT2 inhibitors are more potent glucose-lowering agents

Share:
Was this helpful?

Take the next step with this assignment

Every order includes a free originality report, unlimited revisions and 24/7 human support.

  • Subject expert matched to your exact course
  • Original work, written from scratch for you
  • On-time delivery, with free revisions
Purchase This Solution Order a Custom Written Paper

Secure checkout · Confidential service · No reselling

Keep reading

Join the discussion

Powered by CookieAdmin